Citation
Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut 2013 Nov 12 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/24221456.
Critical appraisals
Compare quality appraisals for each clinical question
- What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma? (compare critical appraisals)
- Are there groups of patients with non-dysplastic BO that require more frequent surveillance? (compare critical appraisals)
- Are there groups of patients with BO that can be discharged from surveillance? (compare critical appraisals)
Cited by
- Are there groups of patients with BO that can be discharged from surveillance?
- Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
- What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
Social links